Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 2 for:    VAL--083
Previous Study | Return to List | Next Study

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
DelMar Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01478178
First received: November 14, 2011
Last updated: October 30, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)